Aim: In recent years, patients with acute coronary syndrome (ACS) are significantly younger.
We hypothesized that the capacity of HDL to accept cholesterol from macrophages, via
cholesterol efflux capacity (CEC) would serve as a predictor of atherosclerotic disease.
Hence, we aim to compare CEC of young ACS to a healthy control cohort.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
P2.6.225
Identification
Copyright
© 2018 Published by Elsevier Inc.
